Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

31.7%

% of GNOM's 41 holdings also in XDNA

56.5%

% of XDNA's 23 holdings also in GNOM

Overlap by Weight
Sector Drift (GNOM minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in GNOM
Weight
in XDNA
Overlap
CRISPR THERAPEUTICS AG 6.3% 15.1% 6.3%
BEAM THERAPEUTICS, INC. 3.7% 13.7% 3.7%
INTELLIA THERAPEUTICS, INC. 3.1% 8.7% 3.1%
AGILENT TECHNOLOGIES INC 3.7% 2.7% 2.7%
VERTEX PHARMACEUTICALS INC 1.7% 1.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to XDNA
ENI SPA-SPONSORED ADR 6.9%
NATERA INC 5.1%
ULTRAGENYX PHARMACEUTICAL IN 4.4%
ARROWHEAD PHARMACEUTICALS, INC. 3.8%
SAREPTA THERAPEUTICS INC 3.7%
MODERNA, INC. 3.7%
ROCKET PHARMACEUTICALS, INC. 3.6%
10X GENOMICS INC CLASS A 3.6%
BIO-TECHNE CORPORATION 3.4%
BIOMARIN PHARMACEUTICAL INC 3.3%
GNOM Underweight Relative to XDNA
BEAM THERAPEUTICS, INC. -10.0%
THERMO FISHER SCIENTIFIC INC -9.5%
CRISPR THERAPEUTICS AG -8.9%
PRIME MEDICINE, INC. -5.9%
INTELLIA THERAPEUTICS, INC. -5.6%
EDITAS MEDICINE, INC. -4.7%
CARIBOU BIOSCIENCES, INC. -3.8%
ABBVIE INC -3.8%
POSEIDA THERAPEUTICS, INC. -3.7%
VERVE THERAPEUTICS, INC. -3.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY